The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Resveratrol alleviates alcoholic fatty liver in mice
Abstract
Alcoholic fatty liver is associated with inhibition of sirtuin 1 (SIRT1) and AMP-activated kinase (AMPK), two critical signaling molecules regulating the pathways of hepatic lipid metabolism in animals. Resveratrol, a dietary polyphenol, has been identified as a potent activator for both SIRT1 and AMPK. In the present study, we have carried out in vivo animal experiments that test the ability of resveratrol to reverse the inhibitory effects of chronic ethanol feeding on hepatic SIRT1-AMPK signaling system and to prevent the development of alcoholic liver steatosis. Resveratrol treatment increased SIRT1 expression levels and stimulated AMPK activity in livers of ethanol-fed mice. The resveratrol-mediated increase in activities of SIRT1 and AMPK was associated with suppression of sterol regulatory element binding protein 1 (SREBP-1) and activation of peroxisome proliferator-activated receptor γ coactivator α (PGC-1α). In parallel, in ethanol-fed mice, resveratrol administration markedly increased circulating adiponectin levels and enhanced mRNA expression of hepatic adiponectin receptors (AdipoR1/R2). In conclusion, resveratrol treatment led to reduced lipid synthesis and increased rates of fatty acid oxidation and prevented alcoholic liver steatosis. The protective action of resveratrol is in whole or in part mediated through the upregulation of a SIRT1-AMPK signaling system in the livers of ethanol-fed mice. Our study suggests that resveratrol may serve as a promising agent for preventing or treating human alcoholic fatty liver disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Resveratrol, an activator of SIRT1, can increase the levels of SREBP in livers of alcohol-treated mice.
“First, resveratrol, an activator of SIRT1, can increase the levels of SREBP in livers of alcohol-treated mice (Ajmo et al. 2008).”
From Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP (2010) · cites this paper as Ajmo et al. 2008
Citations
Cites
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160
Xu, A., Wang, Y., Keshaw, H., Xu, L. Y., Lam, K. S. L., & Cooper, G. J. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317797 · Cited by 1,298
Mechanism of Human SIRT1 Activation by Resveratrol
Borra, M. T., Smith, B. C., & Denu, J. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501250200 · Cited by 1,065
SIRT1 Regulates Hepatocyte Lipid Metabolism through Activating AMP-activated Protein Kinase
Hou, X., Xu, S., Maitland-Toolan, K. A., Sato, K., Jiang, B., Ido, Y., Lan, F., Walsh, K., Wierzbicki, M., Verbeuren, T. J., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802187200 · Cited by 778
Tsuchida, A., Yamauchi, T., Ito, Y., Hada, Y., Maki, T., Takekawa, S., Kamon, J., Kobayashi, M., Suzuki, R., Hara, K., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402367200 · Cited by 550
Tuma, D. J., Thiele, G. M., Xu, D., Klassen, L. W., & Sorrell, M. F. (1996) · Hepatology · doi:10.1002/hep.510230431 · Cited by 245
Østergård, T., Andersen, J. L., Nyholm, B., Lund, S., Nair, K. S., Saltin, B., & Schmitz, O. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00012.2005 · Cited by 88
Alcohol alters hepatic FoxO1, p53, and mitochondrial SIRT5 deacetylation function
Lieber, C. S., Leo, M. A., Wang, X., & DeCarli, L. M. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.06.006 · Cited by 71
Flagged first, then by citations
Research works printed but not linked: 49
- 10.1016/j.molcel.2007.01.011 · DOI
- 10.1038/nrd2060 · DOI · Paper page
- 10.1038/nrm1616 · DOI
- 10.1186/1471-230X-6-1 · DOI
- 10.1210/en.2007-1355 · DOI
- 10.1152/ajpendo.00387.2006 · DOI
- 10.1371/journal.pmed.0040076 · DOI · Paper page
- 10.1126/science.1099196 · DOI · Paper page
- 10.1124/jpet.102.047217 · DOI
- 10.1152/ajpgi.00542.2004 · DOI
- 10.1111/j.1530-0277.2007.00407.x · DOI
- 10.1016/j.phytochem.2007.09.014 · DOI
- 10.1074/jbc.M302140200 · DOI
- 10.1074/jbc.M412357200 · DOI
- 10.1016/j.devcel.2008.02.004 · DOI
- 10.1016/j.biochi.2007.09.019 · DOI
- 10.1038/sj.emboj.7601633 · DOI · Paper page
- 10.1016/j.cmet.2007.12.007 · DOI
- 10.1016/S0016-5085(03)00276-2 · DOI
- 10.1016/j.jhep.2006.05.009 · DOI
- 10.1074/jbc.M500655200 · DOI · Paper page
- 10.1016/j.febslet.2008.06.005 · DOI
- 10.1093/alcalc/agh256 · DOI
- 10.1016/j.lfs.2006.11.044 · DOI
- 10.1016/j.bbrc.2005.12.011 · DOI
- 10.1016/j.bbrc.2008.03.005 · DOI · Paper page
- 10.2174/187153008784534385 · DOI
- 10.1517/14728222.12.1.91 · DOI
- Nakae J, Cao Y, Daitoku H, Fukamizu A, Ogawa W, Yano Y, Hayashi Y. The LXXLL motif of murine forkhead transcription factor FoxO1 mediates Sirt1-dependent transcriptional activity. J Clin Invest 116: 2473–2483, 2006. · DOI
- 10.1038/nature02583 · DOI
- 10.1074/jbc.M607215200 · DOI
- 10.1128/MCB.02279-06 · DOI
- 10.1023/A:1011927113563 · DOI
- 10.1073/pnas.0702509104 · DOI · Paper page
- 10.1002/hep.22074 · DOI
- 10.1152/ajpendo.00629.2006 · DOI
- 10.1016/j.cmet.2007.08.014 · DOI · Paper page
- 10.1007/s00125-006-0228-1 · DOI
- 10.1152/japplphysiol.00349.2003 · DOI
- 10.1053/j.gastro.2003.12.008 · DOI · Paper page
- 10.1097/01.alc.0000191126.11479.69 · DOI
- 10.1111/j.1460-9568.2006.04807.x · DOI
- 10.1016/j.taap.2007.06.018 · DOI
- 10.1074/jbc.M202411200 · DOI
- 10.1053/j.gastro.2004.09.049 · DOI · Paper page
- 10.1093/jn/138.3.497 · DOI
- 10.1002/hep.20821 · DOI
- 10.1152/ajpgi.00575.2007 · DOI
- 10.2337/db05-1188 · DOI
Cited by
Sorted by citations
Sirtuins as regulators of metabolism and healthspan
Houtkooper, R. H., Pirinen, E., & Auwerx, J. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3293 · Cited by 2,008
Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets
Zhang, C.-Y., Yuan, W.-G., He, P., Lei, J.-H., & Wang, C.-X. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i48.10512 · Cited by 594
Walker, A. K., Yang, F., Jiang, K., Ji, J.-Y., Watts, J. L., Purushotham, A., Boss, O., Hirsch, M. L., Ribich, S., Smith, J. J., et al. (2010) · Genes & Development · doi:10.1101/gad.1901210 · Cited by 357
Resveratrol: Anti-Obesity Mechanisms of Action
Aguirre, L., Fernández-Quintela, A., Arias, N., & Portillo, M. (2014) · Molecules · doi:10.3390/molecules191118632 · Cited by 205
Lee, J., Hong, S.-W., Chae, S. W., Kim, D. H., Choi, J. H., Bae, J. C., Park, S. E., Rhee, E.-J., Park, C.-Y., Oh, K.-W., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031394 · Cited by 157
SIRT1 Mediates the Effect of GLP-1 Receptor Agonist Exenatide on Ameliorating Hepatic Steatosis
Xu, F., Li, Z., Zheng, X., Liu, H., Liang, H., Xu, H., Chen, Z., Zeng, K., & Weng, J. (2014) · Diabetes · doi:10.2337/db14-0263 · Cited by 114
Ma, J., Guillot, A., Yang, Z., Mackowiak, B., Hwang, S., Park, O., Peiffer, B. J., Ahmadi, A. R., Melo, L., Kusumanchi, P., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci157780 · Cited by 90
Lee, H.-I., McGregor, R. A., Choi, M.-S., Seo, K.-I., Jung, U. J., Yeo, J., Kim, M.-J., & Lee, M.-K. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.09.014 · Cited by 79
Zhang, P., Qiang, X., Zhang, M., Ma, D., Zhao, Z., Zhou, C., Liu, X., Li, R., Chen, H., & Zhang, Y. (2015) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.219832 · Cited by 78
Effects of resveratrol on proliferation and apoptosis in rat ovarian theca-interstitial cells
Wong, D. H., Villanueva, J. A., Cress, A. B., & Duleba, A. J. (2010) · Molecular Human Reproduction · doi:10.1093/molehr/gaq002 · Cited by 76
Pharmacotherapy for alcoholic patients with alcoholic liver disease
Vuittonet, C. L., Halse, M., Leggio, L., Fricchione, S. B., Brickley, M., Haass-Koffler, C. L., Tavares, T., Swift, R. M., & Kenna, G. A. (2014) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp140028 · Cited by 51
Metadata
- Authors
- Ajmo, J. M., Liang, X., Rogers, C. Q., Pennock, B., & You, M.
- Venue
- American Journal of Physiology-Gastrointestinal and Liver Physiology
- Publisher
- American Physiological Society
- Published
- 2008-10
- Volume
- 295
- Issue
- 4
- Pages
- G833-G842
- ISSN
- 0193-1857
- 1522-1547
- Cited by
- 314
- References
- 11
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review